The Realities Of Our Miserable Funding Formulas For Cancer Research

According to the American Cancer Society 28,000 men will die in 2008 from prostate cancer. Prostate Cancer incidence rates are comparable to Breast Cancer rates. Yet, federal funding is significantly higher for Breast Cancer research than for Prostate Cancer. In 2008, there will be virtually the same number of new cases of Prostate Cancer (186,320) [...]

Economic Problems Facing Research Funded By The NIH

Today’s New York Times, in the Sunday opinion section, there was an editorial about the economic problems facing academic research institutions and their young researchers. The problems they are facing is a direct result of the flat budget that The National Institute of Health (NIH) has been given over the last five years. The rate [...]

Bone Mineral Density and ADT

Increasingly, we are using androgen deprivation therapy (ADT) either alone or in combination with radiation therapy for the treatment of localized, high-risk, or the biochemical relapse of prostate cancer (recurrent pc). Many studies have clearly demonstrated that bone mineral density (BMD) loss is rapid, especially during the first year of ADT. As much as 4.6% [...]

By |2008-02-02T14:33:19-05:00February 2nd, 2008|Advanced Prostate Cancer, Financial, Uncategorized|0 Comments
Go to Top